We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVB icon
151
Nuvation Bio
NUVB
$2.19B
$975K 0.02%
+500,000
New +$1.04M
MNTS icon
152
Momentus
MNTS
$80.8M
$966K 0.02%
44,370
+29,567
+200% +$902K
MKZR
153
MacKenzie Realty Capital
MKZR
$2.8M
$833K 0.01%
124,374
-20,200
-14% -$207K
ARBK
154
Argo Blockchain
ARBK
$42.7M
$830K 0.01%
+20,537
New +$1.68M
GROY.WS icon
155
Gold Royalty Corp Warrants
GROY.WS
$145M
$770K 0.01%
2,200,000
WKSP icon
156
Worksport
WKSP
$10.7M
$698K 0.01%
246,548
-113,953
-32% -$343K
ACXP icon
157
Acurx Pharmaceuticals
ACXP
$6.1M
$551K 0.01%
+53,927
New +$434K
SRZN icon
158
Surrozen
SRZN
$258M
$536K 0.01%
+60,000
New +$548K
GE icon
159
GE Aerospace
GE
$378B
$504K 0.01%
+1,958
New +$430K
DLTR icon
160
Dollar Tree
DLTR
$24.9B
$421K 0.01%
+4,248
New +$367K
AJG icon
161
Arthur J. Gallagher & Co
AJG
$63.9B
$412K 0.01%
+1,286
New +$424K
TPL icon
162
Texas Pacific Land
TPL
$27.6B
$405K 0.01%
+1,149
New +$470K
ED icon
163
Consolidated Edison
ED
$39.7B
$403K 0.01%
+4,014
New +$425K
QUCY
164
Quantum Cyber N.V.
QUCY
$27.8M
$402K 0.01%
285,000
+88,400
+45% +$218K
IOT icon
165
Samsara
IOT
$21.9B
$394K 0.01%
+9,912
New +$410K
KMTS
166
Kestra Medical Technologies
KMTS
$1.4B
$379K 0.01%
22,834
+10,334
+83% +$226K
MTEKW icon
167
Maris-Tech Ltd Warrants
MTEKW
$880K
$378K 0.01%
1,261,058
XRT icon
168
State Street SPDR S&P Retail ETF
XRT
$328M
$375K 0.01%
+4,870
New +$353K
MMM icon
169
3M
MMM
$91B
$340K 0.01%
+2,232
New +$319K
CNSP icon
170
CNS Pharmaceuticals
CNSP
$8.14M
$335K 0.01%
+33,833
New +$423K
THO icon
171
Thor Industries
THO
$4B
$309K 0.01%
+3,480
New +$275K
CAG icon
172
Conagra Brands
CAG
$7.04B
$277K ﹤0.01%
+13,554
New +$318K
AMH icon
173
American Homes 4 Rent
AMH
$12.3B
$276K ﹤0.01%
+7,654
New +$283K
SNEX icon
174
StoneX
SNEX
$9.25B
$269K ﹤0.01%
+6,651
New +$250K
CME icon
175
CME Group
CME
$95.2B
$262K ﹤0.01%
+952
New +$259K

Similar funds

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.